Bastian Linder

Bastian Linder

Auto-generated profile, based on publicly available information

Bastian Linder

Genome Biology Unit, European Molecular Biology Laboratory (EMBL), 69117 Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2013 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
GSGeorg Stoll
Georg Stoll
OPOlli P H Pietiläinen
Olli P H Pietiläinen
BLBastian Linder
Bastian Linder
JSJaana Suvisaari
Jaana Suvisaari
CBCornelia Brosi
Cornelia Brosi
APAarno Palotie
Aarno Palotie

1 January 2012 in Genes & Development
Verified
Journal Article
Open access
PDF file
HDHolger Dill
Holger Dill
BLBastian Linder
Bastian Linder
AFAlexander Fehr
Alexander Fehr
UFUtz Fischer
Utz Fischer
Differentiation of neural stem cells (NSCs) to neurons requires the activation of genes controlled by the repressor element 1 (RE1) silencing transcription factor (REST)/neuron-restrictive silencer factor (NRSF) protein complex. Important components of REST/NRSF are phosphatases (termed RNA polymerase II C-terminal domain small phosphatases [CTDSPs]) that inhibit RNA polymerase II and suppress neuronal gene expression in NSCs. Activation of genes controlled by CTDSPs is required for neurogenesis, but how this is achieved is not fully understood. Here we show thatctdsp2is a target of miR-26b, a microRNA that is encoded in an intron of thectdsp2primary transcript. This intrinsic negative feedback loop is inactive in NSCs because miR-26b biogenesis is inhibited at the precursor level. Generation of mature miR-26b is activated during neurogenesis, where it suppresses Ctdsp2 protein expression and is required for neuronal cell differentiation in vivo.

28 July 2008 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
BLBastian Linder
Bastian Linder
OPOliver Plöttner
Oliver Plöttner
MKMatthias Kroiss
Matthias Kroiss
EHEnno Hartmann
Enno Hartmann
BLBernhard Laggerbauer
Bernhard Laggerbauer
UFUtz Fischer
Utz Fischer
Tudor domains are widespread among proteins involved in RNA metabolism, but only in a few cases their cellular function has been analyzed in detail. Here, we report on the characterization of the ubiquitously expressed Tudor domain containing protein Tdrd3. Apart from its Tudor domain, we show that Tdrd3 possesses an oligosaccharide/nucleotide binding fold (OB-fold) and an ubiquitin associated domain capable of binding tetra-ubiquitin. A set of biochemical experiments revealed an interaction of Tdrd3 with FMRP, the product of the gene affected in Fragile X syndrome, and its autosomal homologs FXR1 and FXR2. FMRP has been implicated in the translational regulation of target mRNAs and shown to be a component of stress granules (SG). We demonstrate that overexpression of Tdrd3 in cells induces the formation of SGs and as a result leads to its co-localization with endogenous FMRP in these structures. Interestingly, the disease-associated FMRP missense mutation I304N identified in a Fragile X patient severely impairs the interaction with Tdrd3 in biochemical experiments. We propose a contribution of Tdrd3 to FMRP-mediated translational repression and suggest that the loss of the FMRP–Tdrd3 interaction caused by the I304N mutation might contribute to the pathogenesis of Fragile X syndrome.

3 November 2010 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
BLBastian Linder
Bastian Linder
HDHolger Dill
Holger Dill
AHAnja Hirmer
Anja Hirmer
JBJan Brocher
Jan Brocher
GLGek Ping Lee
Gek Ping Lee
UFUtz Fischer
Utz Fischer
Retinitis pigmentosa (RP) is a common hereditary eye disease that causes blindness due to a progressive loss of photoreceptors in the retina. RP can be elicited by mutations that affect the tri-snRNP subunit of the pre-mRNA splicing machinery, but how defects in this essential macromolecular complex transform into a photoreceptor-specific phenotype is unknown. We have modeled the disease in zebrafish by silencing the RP-associated splicing factor Prpf31 and observed detrimental effects on visual function and photoreceptor morphology. Despite reducing the level of a constitutive splicing factor, no general defects in gene expression were found. Instead, retinal genes were selectively affected, providing the first in vivo link between mutations in splicing factors and the RP phenotype. Silencing of Prpf4, a splicing factor hitherto unrelated to RP, evoked the same defects in vision, photoreceptor morphology and retinal gene expression. Hence, various routes affecting the tri-snRNP can elicit tissue-specific gene expression defects and lead to the RP phenotype.

30 April 2025 in Cell
Verified
Journal Article
Open access
BLBastian Linder
Bastian Linder
PSPuneet Sharma
Puneet Sharma
JWJie Wu
Jie Wu
TBTosca Birbaumer
Tosca Birbaumer
CECristian Eggers
Cristian Eggers
LSLars M. Steinmetz
Lars M. Steinmetz
Chemically modified nucleotides in mRNA are critical regulators of gene expression, primarily through interactions with reader proteins that bind to these modifications. Here, we present a mechanism by which the epitranscriptomic mark N6-methyladenosine (m6A) is read by tRNAs during translation. Codons that are modified with m6A are decoded inefficiently by the ribosome, rendering them "non-optimal" and inducing ribosome collisions on cellular transcripts. This couples mRNA translation to decay. 5-Methoxycarbonylmethyl-2-thiouridine (mcm5s2U) in the tRNA anticodon loop counteracts this effect. This unanticipated link between the mRNA and tRNA epitranscriptomes enables the coordinated decay of mRNA regulons, including those encoding oncogenic signaling pathways. In cancer, dysregulation of the m6A and mcm5s2U biogenesis pathways-marked by a shift toward more mcm5s2U-is associated with more aggressive tumors and poor prognosis. Overall, this pan-epitranscriptomic interaction represents a novel mechanism of post-transcriptional gene regulation with implications for human health.

1 July 2012 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
JYJun Yin
Jun Yin
JBJan Brocher
Jan Brocher
BLBastian Linder
Bastian Linder
AHAnja Hirmer
Anja Hirmer
HSHusvinee Sundaramurthi
Husvinee Sundaramurthi
CWChristoph Winkler
Christoph Winkler
Purpose.: In experimental eye research, zebrafish has become a powerful model for human retina disorders. The purpose of the present study is the characterization of antibodies commonly employed in zebrafish models for rod photoreceptor degeneration. Methods.: The 1D4 monoclonal antibody, developed against bovine rhodopsin, has been widely used in studies addressing structural and functional features of rhodopsin and was reported as an informative marker to stain rod outer segments in both mice and zebrafish. We have used transgenic reporter lines and histologic analysis to determine the photoreceptor types identified by 1D4 and other antibodies in zebrafish. Results.: We demonstrate that 1D4, in contrast to what has been reported previously, does not recognize rod outer segments in zebrafish, but instead labels long double cone outer segments consistent with sequence conservation of the respective epitope. As an alternative marker for zebrafish rods, we characterized the monoclonal antibody zpr-3, which was found to stain outer segments of both rods, as well as double cones. Conclusions.: Our findings highlight the importance to confirm specificity of antibodies in cross-species experiments for correct interpretation of experimental data. Our findings clarify conflicting published information arising from studies using 1D4 and zpr-3 antibodies in zebrafish.